153 related articles for article (PubMed ID: 22526138)
21. Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis.
Oh JY; Kim MK; Wee WR
Jpn J Ophthalmol; 2011 Jan; 55(1):70-1. PubMed ID: 21331698
[No Abstract] [Full Text] [Related]
22. Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
Hugle B; Burgos-Vargas R; Inman RD; O'Shea F; Laxer RM; Stimec J; Whitney-Mahoney K; Duvnjak M; Anderson M; Tse SM
Clin Exp Rheumatol; 2014; 32(3):424-31. PubMed ID: 24387974
[TBL] [Abstract][Full Text] [Related]
23. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
24. [Swiss registry for TNF-alpha blockers in children and adolescents with rheumatological diseases].
Sauvain MJ; Schalm SB; Bérthet G; Bolz D; Cannizzaro E; Hofer M; Kaiser D; Saurenmann RK; Bolt IB
Praxis (Bern 1994); 2010 May; 99(11):649-54. PubMed ID: 20506089
[TBL] [Abstract][Full Text] [Related]
25. Infliximab: a new treatment for rheumatoid arthritis.
Emery P
Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464
[TBL] [Abstract][Full Text] [Related]
26. Off-target activity of TNF-alpha inhibitors characterized by protein biochips.
Feyen O; Lueking A; Kowald A; Stephan C; Meyer HE; Göbel U; Niehues T
Anal Bioanal Chem; 2008 Jul; 391(5):1713-20. PubMed ID: 18344017
[TBL] [Abstract][Full Text] [Related]
27. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
28. Trials reveal promising options for treating juvenile rheumatoid arthritis.
Hampton T
JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
[No Abstract] [Full Text] [Related]
29. Retention on anti-tumour necrosis factor therapy: the Waikato experience.
Ip K; Hartley L; Solanki K; White D
N Z Med J; 2015 May; 128(1415):34-40. PubMed ID: 26117510
[TBL] [Abstract][Full Text] [Related]
30. Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors.
Lerman MA; Lewen MD; Kempen JH; Mills MD
Am J Ophthalmol; 2015 Jul; 160(1):193-200.e1. PubMed ID: 25892124
[TBL] [Abstract][Full Text] [Related]
31. Anti-TNF agents for rheumatoid arthritis.
Seymour HE; Worsley A; Smith JM; Thomas SH
Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
[TBL] [Abstract][Full Text] [Related]
32. Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids.
Brabnikova Maresova K; Jarosova K; Pavelka K; Stepan JJ
Rheumatol Int; 2013 Aug; 33(8):2001-7. PubMed ID: 23370856
[TBL] [Abstract][Full Text] [Related]
33. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
González-Gay MA; Agudo M
Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
[No Abstract] [Full Text] [Related]
34. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry.
Beukelman T; Ringold S; Davis TE; DeWitt EM; Pelajo CF; Weiss PF; Kimura Y;
J Rheumatol; 2012 Sep; 39(9):1867-74. PubMed ID: 22859354
[TBL] [Abstract][Full Text] [Related]
35. A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.
Berrios I; Jun-O'Connell A; Ghiran S; Ionete C
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150616
[TBL] [Abstract][Full Text] [Related]
36. Which TNF inhibitor for rheumatoid arthritis?
Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
[No Abstract] [Full Text] [Related]
37. Infliximab as monotherapy in giant cell arteritis.
Uthman I; Kanj N; Atweh S
Clin Rheumatol; 2006 Feb; 25(1):109-10. PubMed ID: 15902519
[No Abstract] [Full Text] [Related]
38. [Anti-TNF therapy in rheumatoid arthritis].
Yakeuchi T; Amano K
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Feb; 27(1):7-15. PubMed ID: 15045810
[No Abstract] [Full Text] [Related]
39. Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
Taylor PC; Williams RO; Maini RN
Curr Dir Autoimmun; 2000; 2():83-102. PubMed ID: 11791460
[No Abstract] [Full Text] [Related]
40. Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
Weiss PF; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan-DeWitt E; Feudtner C
J Rheumatol; 2018 Jan; 45(1):107-114. PubMed ID: 28916542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
